von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model

Achieving tolerance toward factor VIII (FVIII) remains an important goal of hemophilia treatment. Up to 40% of patients with severe hemophilia A (HA) develop neutralizing antibodies against FVIII, and the only proven treatment to achieve tolerance is infusion of FVIII over prolonged periods in the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Oleshko, Olga, Vollack-Hesse, Nadine, Tiede, Andreas, Hegermann, Jan, Curth, Ute, Werwitzke, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660012/
https://www.ncbi.nlm.nih.gov/pubmed/37756521
http://dx.doi.org/10.1182/bloodadvances.2023010388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660012/
https://www.ncbi.nlm.nih.gov/pubmed/37756521
http://dx.doi.org/10.1182/bloodadvances.2023010388

Ejemplares similares